The Fresh Toast
JUNE 10, 2022
Medical Cannabis For TMJ? Here’s What The Science Says. Millions of people with TMJ struggle with the severe pain and discomfort brought on by this condition. The post Medical Cannabis For TMJ? Here’s What The Science Says appeared first on The Fresh Toast.
NORML
JUNE 10, 2022
"Adults should no longer be stigmatized and disenfranchised because of convictions for marijuana-related activities that are no longer defined as crimes under the law.". The post Governors Sign Legislation Further Facilitating the Expungement of Past Cannabis Convictions appeared first on NORML.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Leafly
JUNE 10, 2022
Who will be King Kong of Cookie Mountain? The post World’s best exotic cannabis decided at the Zalympix Championships June 11 appeared first on Leafly.
NORML
JUNE 10, 2022
"Rather than embracing Oklahoma's robust medical cannabis industry, politicians have instead sought to abruptly tap the breaks. This legislation is largely a solution in search of a problem and it is directly in conflict with the 'free market' principles so often espoused by those elected officials on the right side of the aisle.". The post Oklahoma: Governor Signs Legislation Temporarily Halting Any Further Expansion of State’s Medical Cannabis Industry appeared first on NORML.
Speaker: Jonathan Bench, International Cannabis and Securities Business Attorney at Harris Bricken
The U.S. cannabis industry is still in its infancy, even though states began engaging with legalization in one form or another in the late 1990s. Today, many opportunities exist for individuals and businesses that want to engage in the industry. Some want to directly own licensed businesses, while others prefer to keep the industry at an arm’s length and merely profit from it.
Leafly
JUNE 10, 2022
Leafly's fearless Canadian editor Ashley Keenan joins us to discuss the newest innovation in child-repellent gummy shapes. Yes. They are what you think they are. The post The Roll-up #245: Gummies that’ll make grandma blush appeared first on Leafly.
Medical Cannabis Brief brings together the best content for patients and advocates from the widest variety of industry thought leaders.
Veriheal
JUNE 10, 2022
D.C. passed a bill that protects workers’ cannabis consumption rights, Illinois updated its discriminatory cannabis criminal justice law, and a 5th grader brought cannabis-infused gummies to school. Let’s dive into this week’s cannanews. D.C. Bill Aims to Secure Workers’ Cannabis Consumption Rights. Earlier this week, Washington, D.C.’s city council passed the Cannabis Employment Protections Amendment Act of 2022 (CEPAA).
Canna Law Blog
JUNE 10, 2022
As of yesterday, June 9, 2022, the home cultivation of low tetrahydrocannabinol (THC) cannabis in Thailand is legal. The government is giving away free plants to boot! This constitutes a milestone for cannabis reform in the country and the region at large, but the Thai changes fall short of the “decriminalization” widely touted in the press.
Cannabis Life Network
JUNE 10, 2022
According to the deputy prime minister, Thailand’s easing cannabis laws will bolster the country’s agriculture and tourism sectors. Although not full legalization, Thailand’s easing cannabis laws is different from other nation-states. For example, the government has distributed 1 million cannabis plants among its population. Thailand is the first Asian country to decriminalize cannabis.
MMJ Recs
JUNE 10, 2022
Utah pain management clinics treat a wide range of medical conditions that cause chronic pain symptoms. Pain clinics in Salt Lake City, and throughout the state of Utah, specialize in helping people manage various types of pain and live more fulfilling lives. Utah pain specialists utilize a range of different treatments, including medical marijuana treatment.
TheAnswerPage
JUNE 10, 2022
Has Nabiximols (a 50:50 THC:CBD oral spray) been evaluated as a therapy for cancer-related pain? Yes. A randomized, double-blind, placebo-controlled graded-dose study examining Nabiximols (a 50:50 THC:CBD oral spray) as a therapy for cancer-related pain, demonstrated efficacy and safety at low (1-4 sprays/day) and medium doses (6-10 sprays/day). Adverse events were dose-related and only the high-dose(11-16 sprays/day) group compared unfavorably with placebo.
Expert insights. Personalized for you.
117 
Let's personalize your content